Clinical Trials Directory

Trials / Completed

CompletedNCT01048398

Remifentanil Versus Paracetamol for Pain Treatment External Cephalic Versions.

Remifentanil Versus Placebo for Pain Treatment External Cephalic Versions. Randomized, Controlled and Masked

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Basque Health Service · Other Government
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

BACKGROUND: Between 3-4% of pregnancies carried to term, the fetuses are in breech presentation. The external version is a maneuver gynecological used to turn a breech in cephalic presentation. For treatment of pain suggests the use of μ agonist remifentanil for fast action and elimination. OBJECTIVE: To compare the effectiveness of remifentanil for pain management in external version. PATIENTS: Pregnant for 36 weeks or more with breech presentation who met the inclusion criteria and sign the consent. Participants will be randomized into two groups before the procedure. Group intervention: paracetamol and remifentanil Control group: paracetamol and placebo DETERMINATIONS: VAS pain level, percentage of success of the maneuver and adverse events. Statistical Analysis: Comparison of pain recorded by VAS in both groups and comparison of adverse events

Conditions

Interventions

TypeNameDescription
DRUGremifentanilintervention: intravenous paracetamol 1g and remifentanil 1mg/100ml in 100ml of 0.9% saline.
DRUGparacetamolControl group: intravenous paracetamol 1g

Timeline

Start date
2010-06-01
Primary completion
2011-04-01
Completion
2011-04-01
First posted
2010-01-13
Last updated
2011-04-14

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01048398. Inclusion in this directory is not an endorsement.

Remifentanil Versus Paracetamol for Pain Treatment External Cephalic Versions. (NCT01048398) · Clinical Trials Directory